Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Glenn Shigeo Takata, MD

    TitleAssociate Professor of Clinical Pediatrics
    SchoolKeck School of Medicine of USC
    DepartmentPediatrics
    AddressCHL Mail Stop 76
    Off Campus
    Los Angeles California 90089
    Phone+1 323 669 2110
    Emailgtakata@chla.usc.edu

       Overview 
       Overview
      Dr. Glenn Takata is a pediatrician in Los Angeles, California and is affiliated with Children's Hospital Los Angeles. He received his medical degree from Northwestern University Feinberg School of Medicine and has been in practice for 31 years. He is one of 136 doctors at Children's Hospital Los Angeles who specialize in Pediatrics.


       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Tham E, Calmes HM, Poppy A, Eliades AB, Schlafly SM, Namtu KC, Smith DM, Vitaska MC, McConnell C, Potts AL, Jastrzembski J, Logsdon TR, Hall M, Takata GS. Sustaining and spreading the reduction of adverse drug events in a multicenter collaborative. Pediatrics. 2011 Aug; 128(2):e438-45..
        View in: PubMed
      2. Coker TR, Chan LS, Newberry SJ, Limbos MA, Suttorp MJ, Shekelle PG, Takata GS. Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children: a systematic review. JAMA. 2010 Nov 17; 304(19):2161-9..
        View in: PubMed
      3. Shekelle PG, Takata G, Newberry SJ, Coker T, Limbos MA, Chan LS, Timmer MM, Suttorp MJ, Carter J, Motala A, Valentine D, Johnsen B, Shanman R. Management of Acute Otitis Media: update. Evid Rep Technol Assess (Full Rep). 2010 Nov; (198):1-426..
        View in: PubMed
      4. Takata GS, Taketomo CK, Waite S. Characteristics of medication errors and adverse drug events in hospitals participating in the California Pediatric Patient Safety Initiative. Am J Health Syst Pharm. 2008 Nov 1; 65(21):2036-44..
        View in: PubMed
      5. Sharek PJ, McClead RE, Taketomo C, Luria JW, Takata GS, Walti B, Tanski M, Nelson C, Logsdon TR, Thurm C, Federico F. An intervention to decrease narcotic-related adverse drug events in children's hospitals. Pediatrics. 2008 Oct; 122(4):e861-6..
        View in: PubMed
      6. Takata GS, Mason W, Taketomo C, Logsdon T, Sharek PJ. Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals. Pediatrics. 2008 Apr; 121(4):e927-35..
        View in: PubMed
      7. Toward transparent clinical policies. Pediatrics. 2008 Mar; 121(3):643-6..
        View in: PubMed
      8. Takata GS, Chan LS, Morphew T, Mangione-Smith R, Morton SC, Shekelle P. Evidence assessment of the accuracy of methods of diagnosing middle ear effusion in children with otitis media with effusion. Pediatrics. 2003 Dec; 112(6 Pt 1):1379-87..
        View in: PubMed
      9. Takata GS, Chan LS, Shekelle P, Morton SC, Mason W, Marcy SM. Evidence assessment of management of acute otitis media: I. The role of antibiotics in treatment of uncomplicated acute otitis media. Pediatrics. 2001 Aug; 108(2):239-47..
        View in: PubMed
      Back to TOP